Dr. Gaurav Kharya

MBBS, DCH, DNB (Pediatrics)

Senior Consultant & Clinical Lead – Center for Pediatric Bone Marrow Transplant & Cellular Therapy

25+ Years of Experience
Delhi NCR

Dr. Gaurav Kharya is a globally acclaimed, pioneering giant in the fields of Pediatric Hematology, Oncology, Immunology, and Bone Marrow Transplantation (BMT). With over 25 years of rich medical standing, Dr. Kharya completed his advanced training in the United Kingdom, holding prestigious clinical fellowships at St. Mary’s Hospital (Imperial College NHS Trust, London) and The Great North Children’s Hospital (Newcastle upon Tyne). He is universally recognized as a visionary who has transformed the landscape of cellular therapy in South Asia by introducing cutting-edge protocols for alternative and half-matched (haploidentical) donor transplants. Dr. Kharya’s practice is deeply rooted in empathy, providing hope and life-saving cures to young children battling lethal blood disorders and immune deficiencies. As a leading voice in global hematology, he actively spearheads clinical trials for next-generation gene therapies.

  • Pediatric Bone Marrow Transplantation: Specialized expertise in Matched Unrelated Donor (MUD) and complex Haploidentical (half-matched) transplants.
  • Advanced Cellular Engineering: Global pioneer in executing in-vitro TCR alpha-beta / CD19 depletion protocols for high-safety transplants.
  • Hemato-Oncology & Hemoglobinopathies: Definitively curing complex cases of Thalassemia, Severe Aplastic Anemia, and Sickle Cell Disease.
  • Primary Immunodeficiencies: Providing definitive stem cell cures for children born with severe combined immunodeficiencies (SCID) and genetic errors.
  • Successfully performed over 1,000 complex pediatric bone marrow transplants, maintaining one of the highest survival and safety records globally.
  • Credited with a historic breakthrough in Indian medicine by performing the country’s very first successful Haploidentical BMT for Sickle Cell Disease.
  • Successfully conducted a revolutionary in-vitro T-cell depleted BMT on a critical 4-month-old infant with severe immunodeficiency—marking the smallest child ever transplanted in India.
  • Officially recognized and awarded for performing the single largest series of transplants for Sickle Cell Disease across the Indian subcontinent.
  • Highly sought-after international speaker who has presented groundbreaking research on chimerism analysis and GVHD prophylaxis at premier global BMT forums.
  • Running highly competitive, specialized academic Fellowship programs to train the next generation of global BMT physicians.